YAP1 and ovarian carcinoma: (32) demonstrated that ovarian cancer glycolysis and progression were controlled by LINC00857 by Spiking miR-486-5p, which up-regulated YAP1 and hence regulated the Hippo signaling pathway, which may potentially offer novel insights for therapeutic approaches targeting ovarian cancer.